Literature DB >> 6331910

Molecular characteristics and biological properties (genetic markers) of candidate strains for preparation of live influenza virus vaccines.

Y Z Ghendon.   

Abstract

The biological and molecular properties of both virulent and vaccine types of influenza virus strains are reviewed, including their analysis in laboratory animals and in organ tissue cultures, as well as studies of their genome peculiarities. Methods are discussed for obtaining attenuated donor strains of influenza virus, and the properties of these strains are analysed. The methods of studying the genome composition and the genes carrying mutation lesions in recombinant vaccine strains obtained by recombination of an attenuated donor strain with current epidemic influenza virus variants are also reviewed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6331910      PMCID: PMC2536308     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  30 in total

1.  New live attenuated influenza A/England/42/72 (H3N2) vaccine (Alice): reactogenicity,, immunogenicity, and protection efficacy.

Authors:  M W Rytel; L J Jackson; J E Ferstenfeld; M A Rosenkranz
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

2.  Correlation of pathogenicity and gene constellation of an influenza A virus (fowl plague). I. Exchange of a single gene.

Authors:  C Scholtissek; R Rott; M Orlich; E Harms; W Rohde
Journal:  Virology       Date:  1977-08       Impact factor: 3.616

3.  Live attenuated influenza virus vaccines. Strains with temperature-sensitive defects in P3 protein and nucleoprotein.

Authors:  P Palese; M B Ritchey
Journal:  Virology       Date:  1977-05-01       Impact factor: 3.616

4.  Live influenza vaccine: screening of attenuated virus strains by a 50% ciliary activity inhibition test in organ cultures of ferret trachea.

Authors:  A Boudreault
Journal:  Can J Microbiol       Date:  1979-03       Impact factor: 2.419

5.  Correlation of pathogenicity and gene constellation of influenza A viruses. II. Highly neurovirulent recombinants derived from non-neurovirulent or weakly neurovirulent parent virus strains.

Authors:  C Scholtissek; A Vallbracht; B Flehmig; R Rott
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

6.  Influenza virus infection in newborn rats: a possible marker of attenuation for man.

Authors:  R H Michaels; M I Mahmud; A J Coup; R Jennings; C W Potter
Journal:  J Med Virol       Date:  1978       Impact factor: 2.327

7.  The behaviour in ferrets of two closely related clones of influenza virus of differing virulence for man.

Authors:  G L Toms; R A Bird; S M Kingsman; C Sweet; H Smith
Journal:  Br J Exp Pathol       Date:  1976-02

8.  The infant rat as a model for assessment of the attenuation of human influenza viruses.

Authors:  M I Mahmud; R Jennings; C W Potter
Journal:  J Med Microbiol       Date:  1979-02       Impact factor: 2.472

9.  Influenza virus infection of a newborn rats: virulence of recombinant strains prepared from a cold-adapted, attenuated parent.

Authors:  M I Mahmud; H F Maassab; R Jennings; C W Potter
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

10.  Reaction of squirrel monkeys to intratracheal inoculation with influenza/A/New Jersey/76 (swine) virus.

Authors:  R F Berendt; W C Hall
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

View more
  2 in total

Review 1.  Reverse Genetics Approaches for the Development of Influenza Vaccines.

Authors:  Aitor Nogales; Luis Martínez-Sobrido
Journal:  Int J Mol Sci       Date:  2016-12-22       Impact factor: 5.923

Review 2.  Temperature Sensitive Mutations in Influenza A Viral Ribonucleoprotein Complex Responsible for the Attenuation of the Live Attenuated Influenza Vaccine.

Authors:  Luis Martínez-Sobrido; Olve Peersen; Aitor Nogales
Journal:  Viruses       Date:  2018-10-15       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.